Fecal microbiota capsule transplantation plus immunotherapy as first-line maintenance therapy for patients with malignant solid tumors: A single-arm, dose-escalation, exploratory phase I study
Translational Oncology · 2027-01 · 75 · 103106
DOI: 10.1016/j.tranon.2026.103106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Oncology, 2027-01. Verfasst von Yunqian Chu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second People's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Changzhou, China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Changzhou Science and Technology Bureau.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, The Second People's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Changzhou, China.
- Nanjing Medical University, Nanjing, China.
- The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, China.
- State Key Laboratory of Systems Medicine for Cancer, NHC Key Laboratory of Digestive Diseases, Division of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Ins…
- Department of Oncology, The Second People's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Changzhou, China. Electronic address: czeyjh@njmu.edu.cn.
- Department of Oncology, The Second People's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Changzhou, China. Electronic address: wenyu.zhu@njmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Changzhou Science and Technology Bureau
Zitieren
APA
Chu, Y., Qian, Y., Shi, J., Hu, M., Ling, R., Wu, Y., Dai, H., Yan, Z., Xian, Q., Chen, H., Jiang, H., & Zhu, W. (2027). Fecal microbiota capsule transplantation plus immunotherapy as first-line maintenance therapy for patients with malignant solid tumors: A single-arm, dose-escalation, exploratory phase I study. Translational Oncology, 75, 103106. https://doi.org/10.1016/j.tranon.2026.103106
Vancouver
Chu Y, Qian Y, Shi J, Hu M, Ling R, Wu Y, et al. Fecal microbiota capsule transplantation plus immunotherapy as first-line maintenance therapy for patients with malignant solid tumors: A single-arm, dose-escalation, exploratory phase I study. Translational Oncology. 2027;75:103106. doi:10.1016/j.tranon.2026.103106
BibTeX
@article{Chu2027,
author = {Chu, Yunqian and Qian, Yuling and Shi, Jing and Hu, Muni and Ling, Rui and Wu, Yuning and Dai, Hanjue and Yan, Zhiying and Xian, Qingying and Chen, Haoyan and Jiang, Hua and Zhu, Wenyu},
title = {Fecal microbiota capsule transplantation plus immunotherapy as first-line maintenance therapy for patients with malignant solid tumors: A single-arm, dose-escalation, exploratory phase I study},
journal = {Translational Oncology},
year = {2027},
volume = {75},
pages = {103106},
doi = {10.1016/j.tranon.2026.103106}
}
EUVIMED